PUBLICATION

Total saponins of panaxnotoginseng promotes lymphangiogenesis by activation VEGF-C expression of lymphatic endothelial cells

Authors
Li, J., Chen, Y., Zhang, L., Xing, L., Xu, H., Wang, Y., Shi, Q., Liang, Q.
ID
ZDB-PUB-160825-10
Date
2016
Source
Journal of ethnopharmacology   193: 293-302 (Journal)
Registered Authors
Keywords
Acrylamide (PubChemCID:6579), Ammonium Persulfate (PubChemCID:62648), Chloroform (PubChemCID:6212), Dimethyl sulfoxide (DMSO) (PubChem CID: 679), Ethanol (PubChem CID: 702), Glycine (PubChemCID:750), Lymphangiogenesis, Lymphedema, MAZ51, VEGF Receptor 3 Kinase inhibitor (PubChemCID:9839842), Methanol (PubChemCID:887), PD98059 (PubChemCID: 4713), SB203580 (PubChemCID: 176155 ), SP600125 (PubChemCID: 8515), Saponins of panaxnotoginseng, Sodium chloride (PubChemCID:5234), Vascular endothelial growth factors C, Wortmannin (PubChemCID: 312145)
MeSH Terms
  • Animals
  • Animals, Genetically Modified
  • Cell Line
  • Endothelial Cells/enzymology
  • Endothelial Cells/metabolism*
  • Lymphangiogenesis/drug effects*
  • MAP Kinase Signaling System
  • Mice
  • Panax notoginseng/chemistry*
  • Phosphatidylinositol 3-Kinases/metabolism
  • Saponins/pharmacology*
  • Signal Transduction
  • Vascular Endothelial Growth Factor C/metabolism*
  • Zebrafish/embryology
  • p38 Mitogen-Activated Protein Kinases/metabolism
PubMed
27553977 Full text @ J. Ethnopharmacol.
Abstract
Lymphatic system plays an important role in maintaining the fluid homeostasis and normal immune responses, anatomic or functional obstruction of which leads to lymphedema, and treatments for therapeutic lymphangiogenesis are efficiency for secondary lymphedema. Total saponins of panaxnotoginseng (PNS) are a mixture isolated from Panaxnotoginseng (Burkill) F.H.Chen, which has been used as traditional Chinese medicine in China for treatment of cardio- and cerebro-vascular diseases. The aim of this study was to determine the effect and mechanism of PNS on lymphangiogenesis.
The Tg (fli1:egfp; gata1:dsred) transgenic zebrafish embryos were treated with different concentrations of PNS (10, 50, 100μM) for 48hours with or without the 6hours pretreatment of the 30μM Vascular endothelial growth factors receptor (VEGFR)-3 kinase inhibitor, followed with morphological observation and lympangiogenesis of thoracic duct assessment. The effect of PNS on cell viability, migration, tube formation and Vascular endothelial growth factors (VEGF)-C mRNA and protein expression of lymphatic endothelial cells (LECs) were determined. The role of phosphatidylinositol-3 (PI-3)-kinase (PI3K), extracellular signal-regulated kinase (ERK)1/2 pathways, c-Jun N-terminal kinase (JNK) and P38 mitogen activated protein kinases (MAPK) signaling in PNS-induced VEGF-C expression of LECs by using pharmacological agents to block each signal.
PNS promotes lymphangiogenesis of thoracic duct in zebrafish with or without VEGFR3 Kinase inhibitor pre-impairment. PNS promotes proliferation, migration and tube formation of LECs. The tube formation induced by PNS could be blocked by VEGFR3 Kinase inhibitor. PNS induce VEGF-C expression of LEC, which could be blocked by ERK1/2, PI3K and P38MAPK signaling inhibitors.
PNS activates lymphangiogenesis both in vivo and in vitro by up-regulating VEGF-C expression and activation of ERK1/2, PI3K and P38MAPK signaling. These findings provide a novel insight into the role of PNS in lymphangiogenesis and suggest that it might be an attractive and suitable therapeutic agent for treating secondary lymphedema or other lymphatic system impairment related disease.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping